Heart Disease Clinical Trials in North Carolina

Showing 241-260 of 514 trials

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

NCT04669548

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

Intraabdominal HypertensionAbdominal Compartment SyndromeAcute Kidney Injury+1 more

Potrero Medical2,500 participantsStarted Dec 2020

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +6 more locations

TERMINATEDNA41 miles

SHIELD II Clinical Investigation

NCT02468778

The HeartMate PHP System is a temporary (\<6 hours) ventricular assist device indicated for use during high-risk percutaneous coronary interventions (PCI) performed electively or urgently in hemodynamically stable patients with severe coronary artery disease, when a heart team, including a cardiac surgeon, has determined high-risk PCI is the appropriate therapeutic option. Use of the HeartMate PHP Systems in these patients may prevent hemodynamic instability, which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri-and post-procedural adverse events.

Coronary Artery Disease

Abbott Medical Devices54 participantsStarted Aug 2015

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +55 more locations

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

SHIELD II Clinical Investigation

Heart Disease Trials in Other Cities

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

MOMENTUM 3 Continued Access Protocol

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

MOMENTUM 3 IDE Clinical Study Protocol

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Physiologic Assessment of Coronary Stenosis Following PCI

The Product Surveillance Registry REVERSE Post Approval Study

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

Imaging of Coronary Plaques in Participants Treated With Evolocumab

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427

SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support?

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

HeartMate 3™ CE Mark Clinical Investigation Plan

Other Conditions in North Carolina